Imatinib in melanoma: a selective treatment option based on KIT mutation status?
- PMID: 17327598
- DOI: 10.1200/JCO.2006.08.9664
Imatinib in melanoma: a selective treatment option based on KIT mutation status?
Comment on
-
Somatic activation of KIT in distinct subtypes of melanoma.J Clin Oncol. 2006 Sep 10;24(26):4340-6. doi: 10.1200/JCO.2006.06.2984. Epub 2006 Aug 14. J Clin Oncol. 2006. PMID: 16908931
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
